Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Evaluate Pharma Orphan Drug Report 2020
What will the orphan drug landscape look like in 2024?
Big pharma's recent dominance of the orphan market has fuelled calls to reform the orphan drug act in the US. Regardless, orphan drug sales are forecast to increase from $119bn in 2018 to $217bn in 2024.
Download your copy of the Evaluate Pharma Orphan Drug Report 2020 to learn more, including:
- Which company leads with a 7.6% share of the orphan market in 2024.
- Which orphan drug is expected to fetch $10bn in 2024, alone.
- What % of WW sales will pipeline orphan drugs make up in 2024.
